Establishing Physiologic Outcomes for Ventricular Unloading on VA ECMO

Launched by UNIVERSITY OF UTAH · Dec 12, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how well a specific treatment called veno-arterial extracorporeal membrane oxygenation (VA ECMO) helps patients with a serious condition known as cardiogenic shock. The study aims to understand how changes in heart function and certain blood tests relate to the effectiveness of VA ECMO in relieving pressure on the heart. Essentially, researchers want to learn more about how this treatment can improve heart health in patients who are facing this critical condition.

To participate in this trial, you need to be at least 18 years old and have been diagnosed with cardiogenic shock. There are no specific exclusions, so if you meet these criteria, you might be eligible. If you choose to take part, you can expect to have your heart function monitored through ultrasound and your blood tested to gather important information. This research could help improve treatments for future patients with similar health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are 18 years of age or older
• • Patients with cardiogenic shock
• • Patients with mechanical circulatory support, specifically veno-arterial extracorporeal membrane oxygenation (VA ECMO) inserted peripherally
• Exclusion Criteria:
• • None